Health Care • Medical/Nursing Services
$71.02 ▲ +6.33
(+9.79%)
MKT CAP: $2.12B • VOL: 921.8K
52W L $32 52W H $171
WGS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $427.5M | $305.4M | $202.6M |
| YoY Revenue Growth % | +40.0% | +50.8% | — |
| Gross Profit | $298.2M | $194.4M | — |
| Gross Margin % | 69.7% | 63.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$13.1M | -$23.2M | -$180.6M |
| Operating Margin % | -3.1% | -7.6% | -80.0% |
| Net Income (GAAP) | -$21.0M | -$52.3M | -$175.8M |
| EBITDA (Normalized) | $2.1M | -$18.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $33.3M | -$28.5M | -$180.1M |
| Capital Expenditures (CapEx) | $19.0M | $5.5M | — |
| Free Cash Flow (FCF) | $14.3M | -$34.0M | -$180.1M |
| FCF Margin % | 3.3% | -11.1% | -80.0% |
| Return on Invested Capital (ROIC %) | -4.1% | -8.7% | — |
| Cash & Short-Term Equivalents | $105.0M | $85.2M | — |
| Total Debt (Short + Long Term) | $48.2M | $51.9M | — |
| Total Stockholders' Equity | $308.2M | $245.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR WGS.